Company / Working Capital
Amgen Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$3.6B
FY2025
5-year range
$3.6B / $11.9B
FY2021-FY2025
Trend
-39.8%
vs FY2024
Sector context
#13 of 215
Health Care
What the data says
Among 215 Health Care companies, Amgen is in the top 6% for working capital. Working Capital has fluctuated over the past 10 years, ranging from $3.6B in FY2025 to $40.5B in FY2017.
Based on SEC 10-K filings.
$3.6B in FY2025 with a 5-year CAGR of -17.8%. Top quartile in the Health Care sector.
Declined from $11.9B to $3.6B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -18.1%
- 5-Year CAGR
- -17.8%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 215This company $3.6B Sector average $957.8M
▼
+272.5% above sector average
Key checks
Key Insights
- 5-year CAGR of -17.8%, indicating a declining trend.
- In FY2025, working capital decreased 39.8% year-over-year.
- Ranks #13 out of 215 companies in the Health Care sector.
- Peak working capital was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.6B | -39.8% |
| FY2024 | $5.9B | -50.3% |
| FY2023 | $11.9B | +83.7% |
| FY2022 | $6.5B | -9.7% |
| FY2021 | $7.2B | -24.1% |
| FY2020 | $9.5B | +69.3% |
| FY2019 | $5.6B | -76.8% |
| FY2018 | $24.1B | -40.4% |
| FY2017 | $40.5B | +16.2% |
| FY2016 | $34.8B | +16.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026